Lactobacillus reuteri DSM 17938 and vitamin D3 in common clinical problems of infants
DOI:
https://doi.org/10.15574/SP.2021.113.68Keywords:
vitamin D, infants, respiratory infections, functional gastrointestinal disorders, Lactobacillus reuteri DSM 17938Abstract
Purpose — to demonstrate the clinical significance of Lactobacillus reuteri DSM 17938 and vitamin D3 in common clinical problems in infants.
Materials and methods. Clinical cases in pediatrics of infancy in children with infant colic (G4), infant regurgitation (G1), functional constipation (G7) are presented. Some international recommendations regarding a preventive dose of vitamin D in the first year of a child' life are considered.
Results. The behavior of an infant is often a concern for parents and is a reason for seeking medical help. In particular, it has been shown when acute crying of a child is associated with threatening conditions. The prevalence of functional gastrointestinal disorders and the importance of using the Rome IV criteria in practice are emphasized. Clinical examples of infant colic (G4), infant regurgitation (G1), functional constipation (G7) demonstrated the management of patients with the importance of counseling, showing the evidence base for the use of Lactobacillus reuteri DSM 17938 and vitamin D3. Works on the importance of vitamin D for the prevention of respiratory infections and its dosage are presented.
Conclusions. For children in the first year of life with infant colic (G4), infant regurgitation (G1), functional constipation (G7), counseling is important, as well as the use of, in particular, Lactobacillus reuteri DSM 17938. Additional benefits are provided by the combined use of Lactobacillus reuteri DSM 17938 with vitamin D3, which is also discussed for the prevention of respiratory infections. Provided international recommendations for a daily preventive dose of 400 IU of vitamin D for infants.
No conflict of interest was declared by the author.
References
Aglipay M, Birken CS, Parkin PC et al. (2017). Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children. JAMA. 318 (3): 245-254. https://doi.org/10.1001/jama.2017.8708; PMid:28719693 PMCid:PMC5817430
Aponte R, MSHN, Palacios C. (2017). Vitamin D for prevention of respiratory tract infections. E-Library of Evidence for Nutrition Actions (eLENA). World Health Organization. URL: https://www.who.int/elena/titles/commentary/vitamind_pneumonia_children/en/.
Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. (2016, Feb 15). Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology: S0016 5085(16)00182-7.
Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, Fewtrell M, Hojsak I, Mihatsch W, Molgaard C, Shamir R, Turck D, van Goudoever J. (2013, Jun). ESPGHAN Committee on Nutrition. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr. 56 (6): 692-701. https://doi.org/10.1097/MPG.0b013e31828f3c05; PMid:23708639
Chau K, Lau E, Greenberg S, Jacobson S, Yazdani Brojeni P, Verma N et al. (2015, Jan). Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr. 166 (1): 74-78. https://doi.org/10.1016/j.jpeds.2014.09.020; PMid:25444531
Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. (2010 Oct). Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 157 (4): 598-602. Epub 2010 Jun 12. https://doi.org/10.1016/j.jpeds.2010.04.066; PMid:20542295
Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. (2010, Oct 1). Lactobacillus reuteri (DSM 17938) in Infants with Functional Chronic Constipation: A Double-Blind, Randomized, Placebo-Controlled Study. The Journal of Pediatrics. 157 (4): 598-602. https://doi.org/10.1016/j.jpeds.2010.04.066; PMid:20542295
Dalle Carbonare L, Valenti MT, Del Forno F, Caneva E, Pietrobelli A. (2017). Vitamin D: Daily vs. Monthly Use in Children and Elderly - What Is Going On? Nutrients. 9 (7): 652. Published 2017 Jun 24. https://doi.org/10.3390/nu9070652; PMid:28672793 PMCid:PMC5537772
Drossman DA, Hasler WL. (2016). Rome IV - Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 150 (6): 1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035; PMid:27147121
Golden NH, Abrams SA. (2014). Committee on Nutrition Optimizing bone health in children and adolescents. Pediatrics. 134: e1229-e1243. https://doi.org/10.1542/peds.2014-2173; PMid:25266429
Heimbach J, BioGaia AB. (2008). GRAS Notice 000254: Generally Recognized as Safe (GRAS) Determination of Lactobacillus reuteri Strain DSM 17938. Center for Food Safety and Applied Nutrition, Food and Drug Administration: 1-134.
Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L et al. (2014, Mar). Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 168 (3): 228-233. https://doi.org/10.1001/jamapediatrics.2013.4367; PMid:24424513
Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla R. (2011, Apr). Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest. 41 (4): 417-422. https://doi.org/10.1111/j.1365-2362.2010.02425.x; PMid:21114493
Johnson JD, Cocker K, Chang E. (2015, Oct 1). Infantile Colic: Recognition and Treatment. Am Fam Physician. 92 (7): 577-582. PMID: 26447441.
Kliegman Robert. (2020). Nelson Textbook of Pediatrics. Philadelphia, PA. Elsevier: 21.
Koppen IJ, Lammers LA, Benninga MA, Tabbers MM. (2015). Management of Functional Constipation in Children: Therapy in Practice. Paediatr Drugs. 17 (5): 349-360. https://doi.org/10.1007/s40272-015-0142-4; PMid:26259965 PMCid:PMC4768242
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P et al. (2017). Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data BMJ. 356: i6583. https://doi.org/10.1136/bmj.i6583; PMid:28202713 PMCid:PMC5310969
Mi G L, Zhao L, Qiao D D, Kang W Q, Tang M Q, Xu J K. (2015, Jun). Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek. 107 (6): 1547-1553. https://doi.org/10.1007/s10482-015-0448-9; PMid:25876529
NHS. (2020). Vitamin D. Vitamins and minerals. URL: https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/.
Perez Burgos A, Wang Lu, McVey Neufeld KA, Mao Yu-Kang, Ahmadzai M, Janssen JL, Stanisz M A, Bienenstock J, Kunze AW. (2015, Sep 1). The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol. 593 (17): 3943-3957. https://doi.org/10.1113/JP270229; PMid:26084409 PMCid:PMC4575579
Public Health England. (2020). COVID-19 rapid guideline: vitamin D. Scientific Advisory Committee on Nutrition. National Institute for Health and Care Excellence. URL: https://www.nice.org.uk/guidance/ng187/resources/covid19-rapid-guideline-vitamin-d-pdf-66142026720709.
Savino F, Ceratto S, Poggi E, Cartosio ME, Cordero di Montezemolo L, Giannattasio. (2015). A Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938 Beneficial microbes. 6 (3): 245-251. https://doi.org/10.3920/BM2014.0090; PMid:25488262
Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R et al. (2010, Sep). Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 126 (3): e526-533. https://doi.org/10.1542/peds.2010-0433; PMid:20713478
Sung V, Hiscock H, Tang MLK, Mensah FK, Nation ML, Satzke C et al. (2014, Apr 1). Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ. 348: g2107. https://doi.org/10.1136/bmj.g2107; PMid:24690625 PMCid:PMC3972414
Szajewska H, Gyrczuk E, Horvath A. (2013, Feb). Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 162 (2): 257-262. https://doi.org/10.1016/j.jpeds.2012.08.004; PMid:22981952
Urbanska M, Szajewska H. (2014, Oct). The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 173 (10): 1327-1337. https://doi.org/10.1007/s00431-014-2328-0; PMid:24819885 PMCid:PMC4165878
Wagner CL, Greer FR. (2008). American Academy of Pediatrics Section on Breastfeeding; American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 122: 1142-1152. https://doi.org/10.1542/peds.2008-1862; PMid:18977996
World Gastroenterology Organisation Global Guidelines. (2017, Feb). Probiotics and prebiotics. WGOGG. URL: https://www.spg.pt/wp-content/uploads/2015/07/2017-Probiotics-and-Prebiotics.pdf.
Wu RY, Pasyk M, Wang B, Forsythe P, Bienenstock J, Mao Y K, Sharma P, Stanisz AM, Kunze WA. (2013). Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol Motil. 25: e205-e214. https://doi.org/10.1111/nmo.12072; PMid:23316914
Zeevenhooven J, Koppen IJ, Benninga MA. (2017). The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr. 20 (1): 1-13. https://doi.org/10.5223/pghn.2017.20.1.1; PMid:28401050 PMCid:PMC5385301
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Modern Pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
